Auburn studying hepatitis vaccine for canine osteosarcoma

05/9/2013 | AL.com (Alabama)

The Auburn University Research Initiative in Cancer is conducting a study to assess whether a modified hepatitis vaccine can destroy canine cancer cells. Twenty owned dogs with osteosarcoma that have not yet undergone limb amputation will be involved in the study. Researchers hope to use the technique to treat numerous types of cancer in dogs and humans. "Dogs get skin cancer, dogs get blood cancers that are similar to human cancers, dogs get brain cancers ... similar to human cancers ... so what we learn in dogs is very applicable to humans," said veterinarian Bruce Smith, who directs the initiative.

View Full Article in:

AL.com (Alabama)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR